Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia
Clinical trial NCT04679415 · COMPLETED
Trial details
- NCT number
- NCT04679415
- Sponsor
- ImmuneMed, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2021-08-19
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.